Abstract The indirect impact of the COVID-19 pandemic on clinical services in peripheral hospitals is not fully described. We compared the impact of COVID-19 on Cerebral Vascular Accident (CVA) and ST-elevation myocardial infarction (STEMI) management and outcome in an Israeli peripheral hospital. We included 1029 CVA and 497 STEMI patients. Those who arrived during (15/3/2020-15/4/2022) and before (1/1/2018-14/3/2020) the pandemic were demographically comparable. During the pandemic, median time for CVA patients from arrival to imaging was longer (23 vs. 19 minutes, p = 0.001); timing from arrival to tissue Plasminogen Activator administration was similar (49 vs. 45 min, p = 0.61); transfer to another hospital was more common (20.3% vs. 14.4% p = 0.01) and median length of stay (LOS) was shorter (3 vs. 4 days, p < 0.05). Among STEMI patients, median time from arrival to intervention intra- pandemic was shorter (45 vs. 50 minutes p = 0.02); Mean LOS shorter (3.86 vs. 4.48 p = 0.01), and unplanned re-admission less frequent (7.8% vs. 14.6% p = 0.01). Mortality didn’t significantly change. Our data shows no major negative impact of the COVID-19 pandemic on CVA outcomes, and possibly improved care for STEMI patients. Follow-up qualitative studies with neurology and cardiology staff will inform how quality of care was maintained during the crises.
No takes yet. Share an insight, caveat, or question.
Bernstine et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: